Tushar Misra is SVP, Chief Manuf. Officer of Mersana Therapeutics, Inc.. Currently has a direct ownership of 17,966 shares of MRSN, which is worth approximately $32,518. The most recent transaction as insider was on Jan 16, 2024, when has been sold 3,357 shares (Common Stock) at a price of $2.71 per share, resulting in proceeds of $9,097. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18K
0% 3M change
56.13% 12M change
Total Value Held $32,518

TUSHAR MISRA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 16 2024
SELL
Open market or private sale
$9,097 $2.71 p/Share
3,357 Reduced 15.74%
17,966 Common Stock
Jan 14 2024
BUY
Exercise of conversion of derivative security
-
1,458 Added 6.4%
21,323 Common Stock
Jan 13 2024
BUY
Exercise of conversion of derivative security
-
7,083 Added 26.28%
19,865 Common Stock
Aug 17 2023
SELL
Open market or private sale
$2,251 $1.18 p/Share
1,908 Reduced 14.22%
11,507 Common Stock
Aug 16 2023
BUY
Exercise of conversion of derivative security
-
6,250 Added 31.78%
13,415 Common Stock
Jan 17 2023
SELL
Open market or private sale
$2,628 $5.74 p/Share
458 Reduced 7.17%
5,930 Common Stock
Jan 14 2023
BUY
Exercise of conversion of derivative security
-
1,459 Added 18.59%
6,388 Common Stock
Aug 17 2022
SELL
Open market or private sale
$13,341 $7.1 p/Share
1,879 Reduced 30.06%
4,371 Common Stock
Aug 16 2022
BUY
Exercise of conversion of derivative security
-
6,250 Added 50.0%
6,250 Common Stock
TM

Tushar Misra

SVP, Chief Manuf. Officer
Cambridge, MA

Track Institutional and Insider Activities on MRSN

Follow Mersana Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRSN shares.

Notify only if

Insider Trading

Get notified when an Mersana Therapeutics, Inc. insider buys or sells MRSN shares.

Notify only if

News

Receive news related to Mersana Therapeutics, Inc.

Track Activities on MRSN